SCHEMBL1496771

SCHEMBL1496771

OCC(O)CSc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
MAPK1 P28482 2/20 0.46
ALDH1A1 P00352 2/20 0.46
CA1 P00915 4/20 0.45
CA2 P00918 4/20 0.45
CA4 P22748 4/20 0.45
CA7 P43166 4/20 0.45
CA9 Q16790 4/20 0.45
MTNR1A P48039 3/20 0.44
MTNR1B P49286 3/20 0.44
FFAR1 O14842 1/20 0.43
BACE1 P56817 3/20 0.42
MAPT P10636 1/20 0.41
PTGER1 P34995 1/20 0.40
PTGFR P43088 1/20 0.40
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6543393 1.00 MAOA (0.50) MAOAMAOBMAPK1ALDH1A1CA1
SCHEMBL6482093 1.00 MAOA (0.50) MAOAMAOBMAPK1ALDH1A1CA1
SCHEMBL916141 0.89 MAOA (0.56) MAOAMAOBMAPK1ALDH1A1CA1
Alcohol SCHEMBL914156 0.85 MAOA (0.53) MAOAMAOBMAPK1ALDH1A1CA1
SCHEMBL1496704 0.84 BACE1 (0.48) ALDH1A1CA1CA2CA4CA7
SCHEMBL16197373 0.83 HIF1A (0.39) MAOACA1CA2CA4CA7
SCHEMBL11273773 0.82 ALDH1A1 (0.45) ALDH1A1CA1CA2CA4CA7
SCHEMBL16197564 0.81 MAPK1 (0.51) MAPK1ALDH1A1CA1CA2CA4
SCHEMBL24098294 0.81 MAOA (0.48) MAOAMAOBMAPK1ALDH1A1CA1
SCHEMBL1496667 0.81 MAOA (0.53) MAOAMAOBMAPK1ALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP claimed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP claimed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO claimed
US-4384967-A Lubricant composition containing an alkali metal borate and a sulfur-containing polyhydroxy compound CHEVRON RESEARCH COMPANY (US) 1983-05-24 US claimed
EP-3087146-B1 LIQUID POLYMERIZABLE COMPOSITION COMPRISING AN AMIDE OR A THIOAMIDE DERIVATIVE MONOMER AND MINERAL NANOPARTICLES DISPERSED THEREIN, AND ITS USE TO MANUFACTURE AN OPTICAL ARTICLE ESSILOR INT (FR) 2018-01-10 EP disclosed
US-20170002170-A1 LIQUID POLYMERIZABLE COMPOSITION COMPRISING AN AMIDE OR A THIOAMIDE DERIVATIVE MONOMER AND MINERAL NANOPARTICLES DISPERSED THEREIN, AND ITS USE TO MANUFACTURE AN OPTICAL ARTICLE ESSILOR INTERNATIONAL (COMPAGINE GENERALE D'OPTIQUE) (FR) 2017-01-05 US disclosed
US-20170002170-A1 LIQUID POLYMERIZABLE COMPOSITION COMPRISING AN AMIDE OR A THIOAMIDE DERIVATIVE MONOMER AND MINERAL NANOPARTICLES DISPERSED THEREIN, AND ITS USE TO MANUFACTURE AN OPTICAL ARTICLE ESSILOR INTERNATIONAL (COMPAGINE GENERALE D'OPTIQUE) (FR) 2017-01-05 US disclosed
US-20170002170-A1 LIQUID POLYMERIZABLE COMPOSITION COMPRISING AN AMIDE OR A THIOAMIDE DERIVATIVE MONOMER AND MINERAL NANOPARTICLES DISPERSED THEREIN, AND ITS USE TO MANUFACTURE AN OPTICAL ARTICLE ESSILOR INTERNATIONAL (COMPAGINE GENERALE D'OPTIQUE) (FR) 2017-01-05 US disclosed
EP-3087146-A1 LIQUID POLYMERIZABLE COMPOSITION COMPRISING AN AMIDE OR A THIOAMIDE DERIVATIVE MONOMER AND MINERAL NANOPARTICLES DISPERSED THEREIN, AND ITS USE TO MANUFACTURE AN OPTICAL ARTICLE Essilor International (FR) 2016-11-02 EP disclosed
WO-2015092048-A1 LIQUID POLYMERIZABLE COMPOSITION COMPRISING AN AMIDE OR A THIOAMIDE DERIVATIVE MONOMER AND MINERAL NANOPARTICLES DISPERSED THEREIN, AND ITS USE TO MANUFACTURE AN OPTICAL ARTICLE ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2015-06-25 WO disclosed
WO-2015092048-A1 LIQUID POLYMERIZABLE COMPOSITION COMPRISING AN AMIDE OR A THIOAMIDE DERIVATIVE MONOMER AND MINERAL NANOPARTICLES DISPERSED THEREIN, AND ITS USE TO MANUFACTURE AN OPTICAL ARTICLE ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2015-06-25 WO disclosed
US-20110190511-A1 Methods For Preparing Fluoroalkyl Arylsulfinyl Compounds And Fluorinated Compounds Thereto IM&T RESEARCH, INC. (US) 2011-08-04 US disclosed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP disclosed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO disclosed
US-4900847-A Catalytic asymmetric epoxidation MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1990-02-13 US disclosed
EP-0197766-A2 Catalytic asymmetric epoxidation MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1986-10-15 EP disclosed
US-4384967-A Lubricant composition containing an alkali metal borate and a sulfur-containing polyhydroxy compound CHEVRON RESEARCH COMPANY (US) 1983-05-24 US disclosed
US-4209447-A FUNGICIDES, BACTERICIDES JANSSEN PHARMACEUTICA N.V. (BE) 1980-06-24 US disclosed
US-4139540-A FUNGICIDE, BACTERICIDE INTERMEDIATE JANSSEN PHARMACEUTICA N.V. (BE) 1979-02-13 US disclosed
US-3936470-A FUNGICIDES, BACTERICIDES JANSSEN PHARMACEUTICA N.V. (BE) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190511-A1 Methods For Preparing Fluoroalkyl Arylsulfinyl Compounds And Fluorinated Compounds Thereto PFAS, AGPS, FDPS MAOA 292/4885MAOB 96/4885MAPK1 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.